Reading IART? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track IART free→Reading IART? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track IART free→QuarterlyIQ Insights · IART
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
The filing pertains to the approval of an equity incentive plan amendment, not a management change.
of this Current Report on Form 8-K (including the Press Release and selected historical financial information) shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing. Discussion of Adjusted Financial Measures In addition to our GAAP results, we provide certain non-GAAP measures, including organic revenues, ad…
President and Chief Executive Officer — Dr. Stuart M. Essig: Dr. Stuart Essig was appointed as President and Chief Executive Officer, succeeding Mojdeh Poul.
ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT As previously disclosed, on December 18, 2018, certain subsidiaries of Integra LifeSciences Holdings Corporation, a Delaware corporation (the “Company”), entered into a $150 million accounts receivable securitization facility (the “A/R Facility”) to reduce outstanding revolving borrowings under the Company’s senior credit facility and to provide additional liquidity and funding for the ongoing business needs of the Company and its subsidiaries. The d…
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.